Search for: "Lange v. Andrews"
Results 21 - 40
of 127
Sort by Relevance
|
Sort by Date
23 Nov 2023, 1:42 am
In so doing, the court relied on the Division Bench[1]Novartis AG v. [read post]
17 Nov 2023, 6:00 am
Multiple parallel cases This was an interesting feature of the Ocado v AutoStore litigation. [read post]
14 Nov 2023, 4:18 am
On 25 October 2023, HHJ Hacon (sitting as a High Court Judge), rendered his judgment in Philip Morris v Nicoventures[1]. [read post]
3 Nov 2023, 7:15 am
The starting point for Mellor J’s analysis was Kitchin LJ’s judgment in Regeneron v Genentech [2013] EWCA Civ 93. [read post]
23 Oct 2023, 2:56 am
The same principle was affirmed in November 2020 in Philips v. [read post]
17 Oct 2023, 3:40 pm
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eig [read post]
20 Sep 2023, 7:13 am
’ More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 Patent Litigation Through the Unified… [read post]
20 Sep 2023, 7:13 am
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 Patent Litigation Through the Unified Patent Court… [read post]
19 Sep 2023, 8:32 am
Wyeth LLC v. [read post]
5 Sep 2023, 6:14 am
Any error in the Board’s claim construction was harmless and substantial evidence, including the claim language and expert testimony, supported the Board’s findings of motivation to combine (Bot M8 LLC v. [read post]
26 Aug 2023, 9:16 am
Protective letters In the case MyStromer v Revolt Zycling (UPC_CFI_177/2023) the UPC’s local division in Düsseldorf ordered a preliminary injunction, despite the fact that Revolt had filed a protective letter. [read post]
25 Aug 2023, 1:29 am
The board’s claim construction and motivation to combine analysis were supported by the record (Shamoon v. [read post]
2 Aug 2023, 2:14 am
On 25 July 2023, the Court of Appeal handed down its decision in Teva & Sandoz v Astellas[1] concerning the validity of Astellas’ patent to mirabegron for use in the treatment of overactive bladder (“OAB”). [read post]
30 Jul 2023, 3:05 am
Country of origin: new European applications in 2022 v requests for unitary effect On the other hand, proprietors from Asia and the US appear overall less enthusiastic relative to their proportion of European filings. [read post]
26 Jul 2023, 1:53 am
In Sun Pharma v. [read post]
25 Jul 2023, 1:43 am
Or that the credibility of the technical effect is assessed at the priority or filing date (e.g., TGI Paris, October 6, 2009, RG n°07/16446, Teva v. [read post]
24 Jul 2023, 1:41 am
Comment The Court of Appeal noted that it was unfortunate that the trial judge was not referred to Hallen v Brabantia. [read post]
16 Jul 2023, 11:56 pm
More from our authors: Vissers Annotated European Patent Convention 2023 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 Patent Litigation Through the Unified Patent Court… [read post]
9 Jul 2023, 10:59 am
In Jones Lange LaSalle Brokerage, Inc. v. 1441 L Associates, LLC, No. 22-046, JLL represented both parties to an agreement to lease property in northwest Washington, DC. [read post]
6 Jul 2023, 2:55 am
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
